C. Ozturk Et Al. , "Use of venetoclax in combination with hypomethylating agents in patients with acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation," BONE MARROW TRANSPLANTATION , vol.57, no.SUPPL 1, pp.335-336, 2022
Ozturk, C. Et Al. 2022. Use of venetoclax in combination with hypomethylating agents in patients with acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation. BONE MARROW TRANSPLANTATION , vol.57, no.SUPPL 1 , 335-336.
Ozturk, C., Sahin, U., Seval, G. C., Bozdag, S. C., Toprak, S. K., Yuksel, M. K., ... Topcuoglu, P.(2022). Use of venetoclax in combination with hypomethylating agents in patients with acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation. BONE MARROW TRANSPLANTATION , vol.57, no.SUPPL 1, 335-336.
Ozturk, C. Et Al. "Use of venetoclax in combination with hypomethylating agents in patients with acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation," BONE MARROW TRANSPLANTATION , vol.57, no.SUPPL 1, 335-336, 2022
Ozturk, C. Et Al. "Use of venetoclax in combination with hypomethylating agents in patients with acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation." BONE MARROW TRANSPLANTATION , vol.57, no.SUPPL 1, pp.335-336, 2022
Ozturk, C. Et Al. (2022) . "Use of venetoclax in combination with hypomethylating agents in patients with acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation." BONE MARROW TRANSPLANTATION , vol.57, no.SUPPL 1, pp.335-336.
@article{article, author={C. Ozturk Et Al. }, title={Use of venetoclax in combination with hypomethylating agents in patients with acute myeloid leukemia relapsing after allogeneic hematopoietic stem cell transplantation}, journal={BONE MARROW TRANSPLANTATION}, year=2022, pages={335-336} }